Centres represented:

• Kings Health Partners
• Imperial Healthcare
• Barts Health
• QE Birmingham
• Walton Neurosurgical centre, Liverpool
• OCDEM/John Radcliffe Hospital
• Sheffield Teaching Hospitals
• Addenbrookes Hospital
• University Hospitals Leicester
• Norfolk and Norwich Hospital
• National Hospital for Neurology and Neurosurgery

Panel:

• Mr Neil Dorward, Consultant Neurosurgeon, National Hospital for Neurology and Neurosurgery and Lead for Pituitary Disease
• Professor Niamh Martin, Lead for Pituitary disease Imperial Healthcare
• Dr Jane Evanson Consultant Radiologist Barts Health
• Dr Michael Kosmin, Clinical Oncologist and Lead for Proton Beam therapy, UCLH

Timetable

10.30 10.50. Beyond Steroids: Rituximab in IgG4-Related Pituitary Disease. Dr F Wernig and Prof N Martin. Presented by Dr H Esdaile. Imperial Healthcare.

10.50 11.10. Aggressive recurrent prolactinoma treated with multi-modal therapy including 11C-methionine PET targeted stereotactic radiosurgery. Dr B Whitelaw.

Presented by Dr O Ramlochansingh and Dr J Kearney. King s Health Partners.

11.10 11.30. An anxious pregnancy. Dr S O Toole. Presented by Dr M Zaid Seegoolam. Sheffield teaching hospitals.

11.30 11.50. When push comes to shove: challenges in management of pituitary apoplexy during pregnancy - when to intervene? Dr A Pal and Mr S Cudlip. Oxford University Hospitals.

11.50 12.10. Keep at it. Sequential interventions on a stubborn corticotroph adenoma. Prof M Levy and Prof M Gurnell. Presented by Dr H Imtiaz University Hospitals Leicester and Addenbrooke s Hospital, Cambridge.

12.10 12.30. Panel review and discussion of morning cases.

12.30 1.30. Networking, audit/research projects over lunch.

1.30 1.50. Pituitary apoplexy and bilateral 6^th nerve palsies. Miss Catherine Gilkes. Walton Centre, Liverpool. Presented by Dr Saba Raza-Knight.

1.50 2.10. Acromegaly, headaches and a sense of d j vu. Dr Andrew Lansdowne and Dr Dr Frederick Keen, University Hospitals, Cardiff.

2.10 2.30. Primary sellar neurocytoma. Prof N Karavitaki, University Hospitals Birmingham.

2.30 2.50. Tumour shrinkage secondary to pre-operative somatostatin analogue in acromegaly: a role for deferring pituitary surgery. Dr R Ahluwalia. Norfolk and Norwich Hospitals and National Hospital for Neurology and Neurosurgery, London.

2.50 3.10. What next? A stubborn somatotroph in a young patient. Prof M Korbonits. Presented by Dr V Mourogovolou.

3.10 3.30. Panel discussion, final comments, certificates.